Haemonetics (HAE) News Today $59.49 -0.55 (-0.92%) As of 03:16 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Alliancebernstein L.P. Lowers Stock Holdings in Haemonetics Co. (NYSE:HAE)Alliancebernstein L.P. lessened its stake in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 7.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 99,781 shares of the medical instruments supplier's stock afterApril 14 at 3:55 AM | marketbeat.comF M Investments LLC Cuts Stock Position in Haemonetics Co. (NYSE:HAE)F M Investments LLC trimmed its stake in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 48.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 52,339 shares of the medical instApril 13 at 6:17 AM | marketbeat.comExodusPoint Capital Management LP Sells 66,500 Shares of Haemonetics Co. (NYSE:HAE)ExodusPoint Capital Management LP trimmed its position in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 82.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,443 shares of the medical instruments supplier'sApril 13 at 4:47 AM | marketbeat.comGeode Capital Management LLC Lowers Position in Haemonetics Co. (NYSE:HAE)Geode Capital Management LLC trimmed its holdings in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 1.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,181,049 shares of the medical instruments supplier's stock aftApril 13 at 4:39 AM | marketbeat.comIs Haemonetics Corporation (HAE) the Best Russell 2000 Stock to Buy According to Wall Street Analysts?April 11 at 2:32 PM | msn.comHaemonetics (NYSE:HAE) Sets New 12-Month Low - Should You Sell?Haemonetics (NYSE:HAE) Reaches New 1-Year Low - Here's What HappenedApril 10, 2025 | marketbeat.comHaemonetics Co. (NYSE:HAE) Shares Bought by Riverwater Partners LLCRiverwater Partners LLC boosted its stake in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 12.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 50,379 shares of the medical instruments supplier's stock aApril 7, 2025 | marketbeat.comNorges Bank Invests $32.80 Million in Haemonetics Co. (NYSE:HAE)Norges Bank purchased a new stake in shares of Haemonetics Co. (NYSE:HAE - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 420,116 shares of the medical instruments supplier's stock,April 7, 2025 | marketbeat.comHaemonetics Co. (NYSE:HAE) Shares Sold by California Public Employees Retirement SystemCalifornia Public Employees Retirement System cut its stake in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 3.1% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 218,361 shares of the medical instrumApril 6, 2025 | marketbeat.comPrudential Financial Inc. Decreases Stock Holdings in Haemonetics Co. (NYSE:HAE)Prudential Financial Inc. trimmed its stake in Haemonetics Co. (NYSE:HAE - Free Report) by 28.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 40,862 shares of the medical instruments supplier's sApril 4, 2025 | marketbeat.comVanguard Group Inc. Purchases 10,119 Shares of Haemonetics Co. (NYSE:HAE)Vanguard Group Inc. increased its position in Haemonetics Co. (NYSE:HAE - Free Report) by 0.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,179,388 shares of the medical instrumenApril 4, 2025 | marketbeat.comHaemonetics Co. (NYSE:HAE) Holdings Lowered by Wellington Management Group LLPWellington Management Group LLP lowered its stake in Haemonetics Co. (NYSE:HAE - Free Report) by 6.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,940,224 shares of the medical instruments supplieApril 3, 2025 | marketbeat.com3 Reasons to Avoid HAE and 1 Stock to Buy InsteadApril 2, 2025 | msn.comGroupama Asset Managment Purchases Shares of 250,000 Haemonetics Co. (NYSE:HAE)Groupama Asset Managment acquired a new stake in Haemonetics Co. (NYSE:HAE - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 250,000 shares of the medical instruments supplier's stock, valued at approApril 2, 2025 | marketbeat.comMay Hill Capital LLC Makes New Investment in Haemonetics Co. (NYSE:HAE)May Hill Capital LLC bought a new position in shares of Haemonetics Co. (NYSE:HAE - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor bought 17,915 shares of the medical instruments suppApril 2, 2025 | marketbeat.comSchroder Investment Management Group Sells 42,750 Shares of Haemonetics Co. (NYSE:HAE)Schroder Investment Management Group reduced its stake in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 4.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 894,539 shares of the medical instruments supplierApril 2, 2025 | marketbeat.comKLP Kapitalforvaltning AS Acquires Shares of 10,100 Haemonetics Co. (NYSE:HAE)KLP Kapitalforvaltning AS purchased a new stake in shares of Haemonetics Co. (NYSE:HAE - Free Report) in the fourth quarter, according to its most recent filing with the SEC. The firm purchased 10,100 shares of the medical instruments supplier's stock, valued at approximately $789,000. A number ofApril 2, 2025 | marketbeat.comHaemonetics Corp. (HAE): Among the 10 Pro-Life Companies to Invest In Now?April 1, 2025 | msn.comHaemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2025 Results: May 8, 2025March 31, 2025 | prnewswire.comHaemonetics Co. (NYSE:HAE) Receives Average Recommendation of "Moderate Buy" from AnalystsShares of Haemonetics Co. (NYSE:HAE - Get Free Report) have received a consensus rating of "Moderate Buy" from the nine analysts that are covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating, six have assigned a buyMarch 31, 2025 | marketbeat.comHeartland Advisors Inc. Lowers Stake in Haemonetics Co. (NYSE:HAE)Heartland Advisors Inc. cut its position in Haemonetics Co. (NYSE:HAE - Free Report) by 34.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 92,923 shares of the medical instruments sMarch 30, 2025 | marketbeat.comHaemonetics Co. (NYSE:HAE) Shares Sold by Corebridge Financial Inc.Corebridge Financial Inc. trimmed its holdings in Haemonetics Co. (NYSE:HAE - Free Report) by 6.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 81,432 shares of the medical instruments supplier's stock afteMarch 30, 2025 | marketbeat.comQuantbot Technologies LP Makes New Investment in Haemonetics Co. (NYSE:HAE)Quantbot Technologies LP bought a new stake in Haemonetics Co. (NYSE:HAE - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 4,415 shares of the medical instruments supplier's stock, valued at approximatelyMarch 30, 2025 | marketbeat.comZions Bancorporation N.A. Buys 14,762 Shares of Haemonetics Co. (NYSE:HAE)Zions Bancorporation N.A. lifted its stake in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 56.3% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 40,996 shares of the medical instruments supplier's stock after acquiring an additional 14,762 shares durMarch 26, 2025 | marketbeat.com15,294 Shares in Haemonetics Co. (NYSE:HAE) Purchased by Natixis Advisors LLCNatixis Advisors LLC acquired a new stake in Haemonetics Co. (NYSE:HAE - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The fund acquired 15,294 shares of the medical instruments supplier's stock, valued at approximately $1,194,000. Several other instiMarch 26, 2025 | marketbeat.comA Note On Haemonetics Corporation's (NYSE:HAE) ROE and Debt To EquityMarch 24, 2025 | finance.yahoo.com4,696 Shares in Haemonetics Co. (NYSE:HAE) Purchased by Cibc World Markets CorpCibc World Markets Corp bought a new stake in Haemonetics Co. (NYSE:HAE - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 4,696 shares of the medical instruments supplier's stock, valued at appMarch 24, 2025 | marketbeat.com15,802 Shares in Haemonetics Co. (NYSE:HAE) Acquired by Kiker Wealth Management LLCKiker Wealth Management LLC purchased a new position in shares of Haemonetics Co. (NYSE:HAE - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 15,802 shares of the medical insMarch 22, 2025 | marketbeat.comBoston Partners Grows Holdings in Haemonetics Co. (NYSE:HAE)Boston Partners increased its position in Haemonetics Co. (NYSE:HAE - Free Report) by 27.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 536,262 shares of the medical instruments supplier's stock after acqMarch 21, 2025 | marketbeat.comIntech Investment Management LLC Acquires 24,009 Shares of Haemonetics Co. (NYSE:HAE)Intech Investment Management LLC increased its holdings in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 107.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 46,338 shares of the medical instrMarch 21, 2025 | marketbeat.com3 Healthcare Stocks Walking a Fine LineMarch 20, 2025 | finance.yahoo.comThrivent Financial for Lutherans Grows Stock Position in Haemonetics Co. (NYSE:HAE)Thrivent Financial for Lutherans increased its holdings in Haemonetics Co. (NYSE:HAE - Free Report) by 14.9% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,264,294 shares of the medical instruments sMarch 20, 2025 | marketbeat.comNeedham & Company LLC Cuts Haemonetics (NYSE:HAE) Price Target to $104.00Needham & Company LLC lowered their price objective on Haemonetics from $108.00 to $104.00 and set a "buy" rating on the stock in a research report on Tuesday.March 19, 2025 | marketbeat.comWilliam Blair Investment Management LLC Purchases 101,807 Shares of Haemonetics Co. (NYSE:HAE)William Blair Investment Management LLC boosted its position in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 29.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 446,258 shares of the medical instrumMarch 19, 2025 | marketbeat.comHaemonetics price target lowered to $104 from $108 at NeedhamMarch 18, 2025 | markets.businessinsider.comHaemonetics (HAE) Gets a Buy from NeedhamMarch 18, 2025 | markets.businessinsider.comHaemonetics Co. (NYSE:HAE) Shares Sold by Royce & Associates LPRoyce & Associates LP trimmed its stake in Haemonetics Co. (NYSE:HAE - Free Report) by 4.7% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,153,268 shares of the medical instruments supplier's stock after selling 57,278 shares durMarch 17, 2025 | marketbeat.comRaymond James Financial Inc. Takes Position in Haemonetics Co. (NYSE:HAE)Raymond James Financial Inc. purchased a new stake in Haemonetics Co. (NYSE:HAE - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 243,364 shares of the medical instruments supplier's stock, valued at apprMarch 17, 2025 | marketbeat.comHaemonetics FY2025 EPS Estimate Reduced by Zacks ResearchHaemonetics Co. (NYSE:HAE - Free Report) - Equities researchers at Zacks Research reduced their FY2025 EPS estimates for shares of Haemonetics in a research note issued on Thursday, March 13th. Zacks Research analyst R. Department now forecasts that the medical instruments supplier will earn $4.5March 17, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Grows Stock Holdings in Haemonetics Co. (NYSE:HAE)Charles Schwab Investment Management Inc. grew its holdings in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 1.6% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 551,193 shares of the medical instruments supplier's stock after purchasing an additionaMarch 15, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Boosts Stock Position in Haemonetics Co. (NYSE:HAE)Connor Clark & Lunn Investment Management Ltd. boosted its holdings in Haemonetics Co. (NYSE:HAE - Free Report) by 14.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 252,142 shares of the medical instruments supplier's stock after acquiring anMarch 14, 2025 | marketbeat.com106,055 Shares in Haemonetics Co. (NYSE:HAE) Purchased by Wealthfront Advisers LLCWealthfront Advisers LLC bought a new stake in shares of Haemonetics Co. (NYSE:HAE - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 106,055 shares of the medical instruments supplier's stock, valued at approximately $7,849,0March 13, 2025 | marketbeat.comHow Do Investors Really Feel About Haemonetics?March 12, 2025 | benzinga.comHaemonetics Co. (NYSE:HAE) Shares Sold by Victory Capital Management Inc.Victory Capital Management Inc. lowered its position in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 2.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 271,082 shares of theMarch 12, 2025 | marketbeat.comTradeLink Capital LLC Invests $902,000 in Haemonetics Co. (NYSE:HAE)TradeLink Capital LLC purchased a new position in Haemonetics Co. (NYSE:HAE - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 11,557 shares of the medical instruments supplier's stock, valued at approximatMarch 10, 2025 | marketbeat.comAMG National Trust Bank Acquires New Position in Haemonetics Co. (NYSE:HAE)AMG National Trust Bank acquired a new stake in Haemonetics Co. (NYSE:HAE - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 9,744 shares of the medical instruments supplier's stock, valued atMarch 9, 2025 | marketbeat.comHaemonetics Co. (NYSE:HAE) Shares Bought by Global Alpha Capital Management Ltd.Global Alpha Capital Management Ltd. increased its position in Haemonetics Co. (NYSE:HAE - Free Report) by 70.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 17,101 shares of the medical instrumenMarch 9, 2025 | marketbeat.comBank of New York Mellon Corp Sells 15,785 Shares of Haemonetics Co. (NYSE:HAE)Bank of New York Mellon Corp lessened its holdings in Haemonetics Co. (NYSE:HAE - Free Report) by 3.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 386,489 shares of the medical instruments supplier's stock after selMarch 9, 2025 | marketbeat.comHaemonetics Co. (NYSE:HAE) Receives Average Recommendation of "Moderate Buy" from BrokeragesShares of Haemonetics Co. (NYSE:HAE - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the nine analysts that are currently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, one has given a hold raMarch 6, 2025 | marketbeat.comHaemonetics Co. (NYSE:HAE) Sees Large Growth in Short InterestHaemonetics Co. (NYSE:HAE - Get Free Report) saw a significant increase in short interest in the month of February. As of February 15th, there was short interest totalling 6,830,000 shares, an increase of 30.3% from the January 31st total of 5,240,000 shares. Based on an average trading volume of 792,300 shares, the days-to-cover ratio is presently 8.6 days. Currently, 13.8% of the shares of the company are sold short.March 5, 2025 | marketbeat.com Remove Ads Get Haemonetics News Delivered to You Automatically Sign up to receive the latest news and ratings for HAE and its competitors with MarketBeat's FREE daily newsletter. Email Address HAE Media Mentions By Week HAE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HAE News Sentiment▼1.341.00▲Average Medical News Sentiment HAE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HAE Articles This Week▼66▲HAE Articles Average Week Remove Ads Get Haemonetics News Delivered to You Automatically Sign up to receive the latest news and ratings for HAE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Align Technology News Merit Medical Systems News ICU Medical News DENTSPLY SIRONA News QuidelOrtho News Neogen News STAAR Surgical News Cerus News OraSure Technologies News Anika Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:HAE) was last updated on 4/14/2025 by MarketBeat.com Staff From Our PartnersTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredThe rotation into gold miners is on.They’re deeply undervalued gold developers with massive in-the-ground, proven resources - and now, fast-track ...Golden Portfolio | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Haemonetics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Haemonetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
